Improvement in the antifilarial efficacy of doxycycline and rifampicin by combination therapy and drug delivery approach

Journal of Drug Targeting

Volumn 18, Issue 5, 2010, Pages 343-350

  Dangi, Anil ^a   Dwivedi, Varun ^b   Vedi, Satish ^a   Owais, Mohammad ^b   Misra Bhattacharya, Shailja ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Antifilarial activity; Brugia malayi; Drug delivery; Liposome; Lymphatic filariasis; Rifampicin; Wolbachia; doxycycline

Indexed keywords

DIETHYLCARBAMAZINE; DOXYCYCLINE; LIPOSOME; RIFAMPICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHELMINTIC ACTIVITY; ARTICLE; BRUGIA MALAYI; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; ENCAPSULATION; IN VIVO STUDY; MALE; MASTOMYS; MICROFILARIASIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE;

ANIMALS; BRUGIA MALAYI; DIETHYLCARBAMAZINE; DISEASE MODELS, ANIMAL; DOXYCYCLINE; DRUG THERAPY, COMBINATION; FILARIASIS; FILARICIDES; LIPOSOMES; MALE; MURINAE; RIFAMPIN;

EID: 77952189065     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/10611860903450007     Document Type: Article

References (31)

1. Bajpai P, Vedi S, Owais M, Sharma SK, Saxena PN, Misra-Bhattacharya S. (2005). Use of liposomized tetracycline in elimination of Wolbachia endobacterium of human lymphatic filariid Brugia malayi in a rodent model. J Drug Target, 13: 375-381.
2. Bakker-Woudenberg IA, ten Kate MT, Stearne-Cullen LE, Woodle MC. (1995). Efficacy of gentamicin or ceftazidime entrapped in liposomes with prolonged blood circulation and enhanced localization in Klebsiella pneumoniae-infected lung tissue. J Infect Dis, 171: 938-947.
3. Bandi C, Anderson TJ, Genchi C, Blaxter ML. (1998). Phylogeny of Wolbachia in filarial nematodes. Proc Biol Sci, 265: 2407-2413.
4. Billová S, Kizek R, Jelen F, Novotná P. (2003). Square-wave voltammetric determination of cefoperazone in a bacterial culture, pharmaceutical drug, milk, and urine. Anal Bioanal Chem, 377: 362-369.
5. Bosshardt SC, McCall JW, Coleman SU, Jones KL, Petit TA, Klei TR. (1993). Prophylactic activity of tetracycline against Brugia pahangi infection in jirds (Meriones unguiculatus). J Parasitol, 79: 775-777.
6. Chirgwin SR, Coleman SU, Porthouse KH, Nowling JM, Punkosdy GA, Klei TR. (2003a). Removal of Wolbachia from Brugia pahangi is closely linked to worm death and fecundity but does not result in altered lymphatic lesion formation in Mongolian gerbils (Meriones unguiculatus). Infect Immun, 71: 6986-6994.
7. Chirgwin SR, Nowling JM, Coleman SU, Klei TR. (2003b). Brugia pahangi and Wolbachia: the kinetics of bacteria elimination, worm viability, and host responses following tetracycline treatment. Exp Parasitol, 103: 16-26.
8. Debrah AY, Mand S, Marfo-Debrekyei Y, Batsa L, Pfarr K, Buttner M, Adjei O, Buttner D, Hoerauf A. (2007). Macrofilaricidal effect of 4 weeks of treatment with doxycycline on Wuchereria bancrofti. Trop Med Int Health, 12: 1433-1441.
9. Gilbert J, Nfon CK, Makepeace BL, Njongmeta LM, Hastings IM, Pfarr KM, Renz A, Tanya VN, Trees AJ. (2005). Antibiotic chemotherapy of onchocerciasis: in a bovine model, killing of adult parasites requires a sustained depletion of endosymbiotic bacteria (Wolbachia species). J Infect Dis, 192: 1483-1493.
10. Hermans PG, Hart CA, Trees AJ. (2001). In vitro activity of antimicrobial agents against the endosymbiont Wolbachia pipientis. J Antimicrob Chemother, 47: 659-663.
11. Hoerauf A, Mand S, Adjei O, Fleischer B, Büttner DW. (2001). Depletion of Wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment. Lancet, 357: 1415-1416.
12. Hoerauf A, Mand S, Fischer K, Kruppa T, Marfo-Debrekyei Y, Debrah AY, Pfarr KM, Adjei O, Büttner DW. (2003). Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production. Med Microbiol Immunol, 192: 211-216.
13. Karabay O, Sencan I, Kayas D, Sahin I. (2004). Ofloxacin plus rifampicin versus doxycycline plus rifampicin in the treatment of brucellosis: a randomized clinical trial (ISRCTN11871179). BMC Infect Dis, 4: 18.
14. McCall JW, Jun JJ, Bandi C. (1999). Wolbachia and the antifilarial properties of tetracycline: aAn untold story. Italian J Zool, 66: 7-10.
15. McLaren DJ, Worms MJ, Laurence BR, Simpson MG. (1975). Microorganisms in filarial larvae (Nematoda). Trans R Soc Trop Med Hyg, 69: 509-514.
16. Owais M, Misra-Bhattacharya S, Haq W, Gupta CM. (2003). Immunomodulator tuftsin augments antifilarial activity of diethylcarbamazine against experimental brugian filariasis. J Drug Target, 11: 247-251.
17. Rao RU, Moussa H, Weil GJ. (2002). Brugia malayi: effects of antibacterial agents on larval viability and development in vitro. Exp Parasitol, 101: 77-81.
18. Ridtitid W, Wongnawa M, Mahatthanatrakul W, Pattanawongsa A, Bumrungwong N, Sunbhanich M. (2006). Effects of rifampicin and ketoconazole on the pharmacokinetics of a single oral dose of diethylcarbamazine in healthy volunteers. Songkla Med J, 24: 527-536.
19. Sangaré L, Morisset R, Omri A, Ravaoarinoro M. (1998). Incorporation rates, stabilities, cytotoxicities and release of liposomal tetracycline and doxycycline in human serum. J Antimicrob Chemother, 42: 831-834.
20. Sangaré L, Morisset R, Ravaoarinoro M. (1999). In-vitro anti-chlamydial activities of free and liposomal tetracycline and doxycycline. J Med Microbiol, 48: 689-693.
21. Sangaré L, Morisset R, Gaboury L, Ravaoarinoro M. (2001). Effects of cationic liposome-encapsulated doxycycline on experimental Chlamydia trachomatis genital infection in mice. J Antimicrob Chemother, 47: 323-331.
22. Shakya S, Bajpai P, Sharma S, Misra-Bhattacharya S. (2008). Prior killing of intracellular bacteria Wolbachia reduces inflammatory reactions and improves antifilarial efficacy of diethylcarbamazine in rodent model of Brugia malayi. Parasitol Res, 102: 963-972.
23. Singh U, Misra S, Murthy PK, Katiyar JC, Agrawal A, Sircar AR. (1997). Immunoreactive molecules of Brugia malayi and their diagnostic potential. Serodiag Immunother Infect Dis, 8: 207-212.
24. Singleton WS, Gray MS, Brown ML, White JL. (1965). Preparation of egg yolk lecithin. J Am Oil Chem Soc, 42: 53-56.
25. Specht S, Mand S, Marfo-Debrekyei Y, Debrah AY, Konadu P, Adjei O, Büttner DW, Hoerauf A. (2008). Efficacy of 2-and 4-week rifampicin treatment on the Wolbachia of Onchocerca volvulus. Parasitol Res, 103: 1303-1309.
26. Specht S, Wanji S. (2009). New insights into the biology of filarial infections. J Helminthol, 83: 199-202.
27. Supali T, Djuardi Y, Pfarr KM, Wibowo H, Taylor MJ, Hoerauf A, Houwing-Duistermaat JJ, Yazdanbakhsh M, Sartono E. (2008). Doxycycline treatment of Brugia malayi-infected persons reduces microfilaremia and adverse reactions after diethylcarbamazine and albendazole treatment. Clin Infect Dis, 46: 1385-1393.
28. Taylor MJ, Hoerauf A. (1999). Wolbachia bacteria of filarial nematodes. Parasitol Today (Regul Ed), 15: 437-442.
29. Taylor MJ, Makunde WH, McGarry HF, Turner JD, Mand S, Hoerauf A. (2005). Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomized placebocontrolled trial. Lancet, 365: 2116-2121.
30. Turner JD, Mand S, Debrah AY, Muehlfeld J, Pfarr K, McGarry HF, Adjei O, Taylor MJ, Hoerauf A. (2006). A randomized, double-blind clinical trial of a 3-week course of doxycycline plus albendazole and ivermectin for the treatment of Wuchereria bancrofti infection. Clin Infect Dis, 42: 1081-1089.
31. Volkmann L, Fischer K, Taylor M, Hoerauf A. (2003). Antibiotic therapy in murine filariasis (Litomosoides sigmodontis):comparative effects of doxycycline and rifampicin on Wolbachia and filarial viability. Trop Med Int Health, 8: 392-401